MEZZETTI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 15.933
EU - Europa 11.565
AS - Asia 10.261
SA - Sud America 1.036
Continente sconosciuto - Info sul continente non disponibili 469
AF - Africa 143
OC - Oceania 14
Totale 39.421
Nazione #
US - Stati Uniti d'America 15.594
SG - Singapore 3.896
CN - Cina 2.986
UA - Ucraina 1.774
RU - Federazione Russa 1.755
IT - Italia 1.534
IE - Irlanda 1.424
TR - Turchia 1.350
GB - Regno Unito 1.239
SE - Svezia 1.165
DE - Germania 951
FR - Francia 920
BR - Brasile 859
VN - Vietnam 804
IN - India 556
FI - Finlandia 476
CA - Canada 181
BD - Bangladesh 158
HK - Hong Kong 122
MX - Messico 96
PL - Polonia 81
AR - Argentina 69
JP - Giappone 66
ES - Italia 53
IQ - Iraq 52
ZA - Sudafrica 51
NL - Olanda 40
KR - Corea 35
ID - Indonesia 34
PK - Pakistan 33
BE - Belgio 30
CZ - Repubblica Ceca 30
EC - Ecuador 29
IL - Israele 26
CO - Colombia 23
MA - Marocco 23
IR - Iran 21
LT - Lituania 18
UZ - Uzbekistan 18
AT - Austria 17
EU - Europa 16
SA - Arabia Saudita 16
VE - Venezuela 16
EG - Egitto 14
KE - Kenya 14
MY - Malesia 14
JM - Giamaica 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 9
AU - Australia 9
CR - Costa Rica 9
JO - Giordania 9
PH - Filippine 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
CL - Cile 8
DZ - Algeria 8
GR - Grecia 8
RO - Romania 8
HN - Honduras 7
PE - Perù 7
AL - Albania 6
AZ - Azerbaigian 6
ET - Etiopia 6
CH - Svizzera 5
AO - Angola 4
BH - Bahrain 4
CI - Costa d'Avorio 4
DK - Danimarca 4
GT - Guatemala 4
KZ - Kazakistan 4
NI - Nicaragua 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
TW - Taiwan 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
GE - Georgia 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
MU - Mauritius 2
PA - Panama 2
PR - Porto Rico 2
SR - Suriname 2
SV - El Salvador 2
Totale 38.946
Città #
Singapore 2.828
Jacksonville 1.946
San Jose 1.793
Chandler 1.724
Dublin 1.410
Ashburn 961
Southend 886
Izmir 728
Council Bluffs 685
Princeton 675
Beijing 669
Dallas 549
Nanjing 533
Dearborn 406
Los Angeles 396
Wilmington 381
Munich 345
Cambridge 323
The Dalles 323
New York 310
Ho Chi Minh City 287
Santa Clara 272
Tongling 258
Nanchang 214
Ann Arbor 184
Buffalo 174
Hanoi 155
Chieti 153
Altamura 151
Moscow 150
Woodbridge 148
Helsinki 118
Shenyang 116
Boardman 113
Hong Kong 106
São Paulo 105
Hebei 99
Houston 94
Milan 91
Tianjin 90
Rome 79
Washington 73
Jiaxing 72
Montreal 71
Brooklyn 67
Grevenbroich 66
Columbus 65
Warsaw 65
Phoenix 60
Denver 56
Orem 56
Kunming 55
Tokyo 55
Changsha 51
Chennai 50
Hefei 50
Pescara 48
Jinan 47
Toronto 47
Stockholm 46
Chicago 44
Hangzhou 44
Atlanta 43
Da Nang 42
Redondo Beach 42
Rio de Janeiro 40
Johannesburg 39
London 39
Haiphong 38
Mexico City 38
Norwalk 38
San Mateo 38
Seattle 37
Poplar 36
Orange 35
Seoul 33
Frankfurt am Main 31
Manchester 31
Auburn Hills 30
Guangzhou 30
Zhengzhou 29
Augusta 28
Boston 28
Brussels 28
Ningbo 27
Brno 24
Lanzhou 24
Turku 24
Changchun 22
San Francisco 22
Mumbai 21
Baghdad 20
Curitiba 20
Taizhou 19
Belo Horizonte 18
Biên Hòa 18
Querétaro 18
Falls Church 17
Leawood 17
Amsterdam 16
Totale 23.316
Nome #
Vascular characteristic in hypertensive patients with different left ventricular morphology 791
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 558
Rimodellamento concentrico del ventricolo sx in pazienti con ipertensione essenziale: è un pattern geometrico omogeneo? 270
MicroRNA profiling in migraine without aura: Pilot study 258
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 257
Ouabaina endogena, pattern emodinamico e geometria ventricolare sx nell'ipertensione essenziale. 223
A unique microRNA signature associated with plaque instability in humans. 211
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 207
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 200
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 187
Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers 184
Ossidazione delle LDL e vitamine antiossidanti in pazienti ipertesi dipper e nondipper. 180
A prothrombotic state 177
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 176
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 175
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 171
Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: Study design and methodology 170
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 168
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 166
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care 166
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 164
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 162
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 162
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 161
A unique microRNA signature associated with ischemic stroke in humans 159
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 159
Low density lipoprotein oxidation in white coat and sustained hypertension (pubbl. su Am J Hypertension). 158
Low density lipoprotein oxidation and antioxidant vitamins in dipper and nondipper hypertensive patients 158
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 158
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 157
White-coat resistant hypertension 157
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 156
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 156
Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. 155
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study 154
A 31P-Nuclear magnetic resonance study of intermittent warm blood cardioplegia 153
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 153
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 153
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 152
Attività della paraoxonasi sierica in pazienti con ipertensione arteriosa essenziale. 151
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 151
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 151
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 151
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 150
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 149
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 149
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 149
Cephalosporins are scavengers of hypochlorous acid 148
Ipertensione arteriosa ed algosensibilità muscolare 148
Cigarette smoke, ferritin, and lipid peroxidation 148
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 147
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 145
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 144
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 144
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 144
Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. 143
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 143
Guidelines enforcement and clinical outcome 143
Contribution of myofascial trigger points to migraine symptoms 143
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 142
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 142
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 142
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 142
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 141
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 141
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 141
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 140
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 140
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 138
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 138
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 137
Association between 5-lipoxygenase expression and plaque instability in humans. 137
Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. 136
Heightened free radical activity in angina pectoris 136
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 136
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 136
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 135
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 135
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 134
La Sindrome Miofasciale come fattore di attivazione della sintomatologia dolorosa della Fibromialgia 134
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease 134
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 134
Advanced glycation end products in adolescents and young adults with diabetic angiopathy. 133
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 133
(In)accuracy of blood pressure measurement in 14 Italian hospitals 133
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 132
Blood pressure variability and cardiovascular risk in treated hypertensive patients. 132
[Physiopathological bases of the medical treatment of portal hypertension]. 131
The black esophagus 131
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 131
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 130
Ambulatory blood pressure stage 130
Viscero-visceral hyperalgesia: characterization in different clinical models 130
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 130
The (K+)ey of the problem 130
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 129
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 129
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 129
[The role of hypothermia and of potassium-induced cardioplegia in the protection of the ischemic myocardium during aortopulmonary bypass]. 129
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 128
Totale 16.344
Categoria #
all - tutte 149.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.387 0 27 14 304 145 19 23 101 113 41 175 425
2022/20234.677 357 617 246 541 433 977 292 325 605 63 123 98
2023/20242.193 169 74 153 64 117 698 514 60 25 71 15 233
2024/20255.404 320 851 709 72 154 215 196 253 542 239 698 1.155
2025/202611.902 1.017 417 1.028 1.475 1.125 755 1.932 659 1.804 929 628 133
2026/2027862 246 616 0 0 0 0 0 0 0 0 0 0
Totale 39.421